Literature DB >> 32015094

Low Colorectal Cancer Screening Uptake and Persistent Disparities in an Underserved Urban Population.

Katherine Ni1, Kelli O'Connell2, Sanya Anand3, Stephanie C Yakoubovitch3, Simona C Kwon4, Rabia Ali de Latour3, Andrew B Wallach5, Scott E Sherman4, Mengmeng Du2, Peter S Liang6,7.   

Abstract

Colorectal cancer screening has increased substantially in New York City in recent years. However, screening uptake measured by telephone surveys may not fully capture rates among underserved populations. We measured screening completion within 1 year of a primary care visit among previously unscreened patients in a large urban safety-net hospital and identified sociodemographic and health-related predictors of screening.We identified 21,256 patients ages 50 to 75 who were seen by primary care providers (PCP) in 2014, of whom 14,425 (67.9%) were not up-to-date with screening. Because PCPs facilitate the majority of screening, we compared patients who received screening within 1 year of an initial PCP visit to those who remained unscreened using multivariable logistic regression.Among patients not up-to-date with screening at study outset, 11.5% (1,658 patients) completed screening within 1 year of a PCP visit. Asian race, more PCP visits, and higher area-level income were associated with higher screening completion. Factors associated with remaining unscreened included morbid obesity, ever smoking, Elixhauser comorbidity index of 0, and having Medicaid/Medicare insurance. Age, sex, language, and travel time to the hospital were not associated with screening status. Overall, 39.9% of patients were up-to-date with screening by 2015.In an underserved urban population, colorectal cancer screening disparities remain, and overall screening uptake was low. Because more PCP visits were associated with modestly higher screening completion at 1 year, additional community-level education and outreach may be crucial to increase colorectal cancer screening in underserved populations. ©2020 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2020        PMID: 32015094      PMCID: PMC7127936          DOI: 10.1158/1940-6207.CAPR-19-0440

Source DB:  PubMed          Journal:  Cancer Prev Res (Phila)        ISSN: 1940-6215


  27 in total

1.  The effect of fecal occult-blood screening on the incidence of colorectal cancer.

Authors:  J S Mandel; T R Church; J H Bond; F Ederer; M S Geisser; S J Mongin; D C Snover; L M Schuman
Journal:  N Engl J Med       Date:  2000-11-30       Impact factor: 91.245

2.  Comparison of the Elixhauser and Charlson/Deyo methods of comorbidity measurement in administrative data.

Authors:  Danielle A Southern; Hude Quan; William A Ghali
Journal:  Med Care       Date:  2004-04       Impact factor: 2.983

Review 3.  New York Citywide Colon Cancer Control Coalition: A public health effort to increase colon cancer screening and address health disparities.

Authors:  Steven H Itzkowitz; Sidney J Winawer; Marian Krauskopf; Mari Carlesimo; Felice H Schnoll-Sussman; Katy Huang; Thomas K Weber; Lina Jandorf
Journal:  Cancer       Date:  2015-11-23       Impact factor: 6.860

4.  Understanding current racial/ethnic disparities in colorectal cancer screening in the United States: the contribution of socioeconomic status and access to care.

Authors:  David T Liss; David W Baker
Journal:  Am J Prev Med       Date:  2014-03       Impact factor: 5.043

Review 5.  Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.

Authors:  Jennifer S Lin; Margaret A Piper; Leslie A Perdue; Carolyn M Rutter; Elizabeth M Webber; Elizabeth O'Connor; Ning Smith; Evelyn P Whitlock
Journal:  JAMA       Date:  2016-06-21       Impact factor: 56.272

6.  Predictors of Colorectal Cancer Screening Prior to Implementation of a Large Pragmatic Trial in Federally Qualified Health Centers.

Authors:  Amanda F Petrik; Thuy Le; Erin Keast; Jennifer Rivelli; Keshia Bigler; Beverly Green; William M Vollmer; Gloria Coronado
Journal:  J Community Health       Date:  2018-02

7.  Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies.

Authors:  John M Inadomi; Sandeep Vijan; Nancy K Janz; Angela Fagerlin; Jennifer P Thomas; Yunghui V Lin; Roxana Muñoz; Chim Lau; Ma Somsouk; Najwa El-Nachef; Rodney A Hayward
Journal:  Arch Intern Med       Date:  2012-04-09

8.  Protection by endoscopy against death from colorectal cancer. A case-control study among veterans.

Authors:  A D Müller; A Sonnenberg
Journal:  Arch Intern Med       Date:  1995-09-11

9.  Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology.

Authors:  Bernard Levin; David A Lieberman; Beth McFarland; Robert A Smith; Durado Brooks; Kimberly S Andrews; Chiranjeev Dash; Francis M Giardiello; Seth Glick; Theodore R Levin; Perry Pickhardt; Douglas K Rex; Alan Thorson; Sidney J Winawer
Journal:  CA Cancer J Clin       Date:  2008-03-05       Impact factor: 508.702

10.  Patterns and Trends in Cancer Screening in the United States.

Authors:  Ingrid J Hall; Florence K L Tangka; Susan A Sabatino; Trevor D Thompson; Barry I Graubard; Nancy Breen
Journal:  Prev Chronic Dis       Date:  2018-07-26       Impact factor: 2.830

View more
  3 in total

1.  Predictors of Colorectal Cancer Screening Among African American Men Living with HIV.

Authors:  Terri-Ann Kelly; Soojong Kim; Loretta S Jemmott; John B Jemmott
Journal:  J Community Health       Date:  2021-05-08

2.  Spatial Insights for Understanding Colorectal Cancer Screening in Disproportionately Affected Populations, Central Texas, 2019.

Authors:  F Benjamin Zhan; Niaz Morshed; Nicole Kluz; Bretta Candelaria; Eda Baykal-Caglar; Anjum Khurshid; Michael P Pignone
Journal:  Prev Chronic Dis       Date:  2021-03-04       Impact factor: 2.830

3.  Cross-sectional adherence with the multi-target stool DNA test for colorectal cancer screening in a large, nationally insured cohort.

Authors:  Lesley-Ann Miller-Wilson; Lila J Finney Rutten; Jack Van Thomme; A Burak Ozbay; Paul J Limburg
Journal:  Int J Colorectal Dis       Date:  2021-05-21       Impact factor: 2.571

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.